Mutations of the nogo-66 receptor (Rtn4r) gene in schizophrenia

Human Mutation

Volumn 24, Issue 6, 2004, Pages 534-535

  Sinibaldi, Lorenzo ^a,b   De Luca, Alessandro ^a,b   Bellacchio, Emanuele ^a   Conti, Emanuela ^a,b   Pasini, Augusto ^c   Paloscia, Claudio ^c   Spalletta, Gianfranco ^c,d   Caltagirone, Carlo ^c,d   Pizzuti, Antonio ^a,b   Dallapiccola, Bruno ^a,b  

^a IRCCS FONDAZIONE BIETTI   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

LRR; Nogo 66; RTN4R; Schizophrenia; VCFS

Indexed keywords

CELL SURFACE RECEPTOR; MYELIN PROTEIN; RTN4R PROTEIN, HUMAN;

ADULT; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CODON; DIGEORGE SYNDROME; FEMALE; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ITALY; MALE; MIDDLE AGED; MISSENSE MUTATION; MUTATION; NUCLEOTIDE SEQUENCE; SCHIZOPHRENIA;

ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CODON; DIGEORGE SYNDROME; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; MODELS, MOLECULAR; MUTATION; MUTATION, MISSENSE; MYELIN PROTEINS; RECEPTORS, CELL SURFACE; SCHIZOPHRENIA;

EID: 28144437017     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.9292     Document Type: Article

References (25)

1. Barnea-Goraly N, Menon V, Krasnow B, Ko A, Reiss A, Eliez S. 2003. Investigation of white matter structure in velocardiofacial syndrome: a diffusion tensor imaging study. Am J Psychiatry 160(10):1863-1869.
2. Chakravarti A. Population genetics--making sense out of sequence.Nat Genet. 1999 21(1 Suppl):56-60.
3. Carpenter WT Jr, Kirkpatrick B. 1988. The heterogeneity of the long-term course of schizophrenia. Schizophr Bull 14(4):645652.
4. Chen MS, Huber AB, van der Haar ME, Frank M, Schnell L, Spillmann AA, Christ F, Schwab ME. 2000. Nogo-A is a myelinassociated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 403(6768):434-439.
5. De Luca A, Pasini A, Amati F, Botta A, Spalletta G, Alimenti S, Caccamo F, Conti E, Trakalo J, Macciardi F, Dallapiccola B, Novelli G. 2001. Association study of a promoter polymorphism of UFD1L gene with schizophrenia. Am J Med Genet 105(6):529-533.
6. De Luca A, Conti E, Grifone N, Amati F, Spalletta G, Caltagirone C, Bonaviri G, Pasini A, Gennarelli M, Stefano B, Berti L, Mittler G, Meisterernst M, Dallapiccola B, Novelli G. 2003. Association study between CAG trinucleotide repeats in the PCQAP gene (PC2 glutamine/Q-rich-associated protein) and schizophrenia. Am J Med Genet 116B(1):32-35.
7. Domeniconi M, Cao Z, Spencer T, Sivasankaran R, Wang K, Nikulina E, Kimura N, Cai H, Deng K, Gao Y, He Z, Filbin M. 2002. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron 35(2):283290.
8. First MB, Williams JBW, Gibbon M. 1995. Structured Clinical Interview for DSM-IV Patient Edition (SCID-P). Washington, DC: American Psychiatric Press.
9. Fournier AE, GrandPre T, Strittmatter SM. 2001. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 409(6818):341-346.
10. Gottesman II. 1991. Schizophrenia genesis: the origin of madness. New York: Freeman.
11. Jablensky A. 2004. Resolving schizophrenia's CATCH22. Nat Genet 36(7):674-675.
12. Koradi R, Billeter M, and Wüthrich K. 1996. MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graphics 14(1):51-55.
13. Liu H, Heath SC, Sobin C, Roos JL, Galke BL, Blundell ML, Lenane M, Robertson B, Wijsman EM, Rapoport JL, Gogos JA, Karayiorgou M. 2002a. Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia. Proc Natl Acad Sci U S A 99(6):3717-3722.
14. Liu H, Abecasis GR, Heath SC, Knowles A, Demars S, Chen YJ, Roos JL, Rapoport JL, Gogos JA, Karayiorgou M. 2002b. Genetic variation in the 22q11 locus and susceptibility to schizophrenia. Proc Natl Acad Sci U S A 99(26):16859-16864.
15. Mi S, Lee X, Shao Z, Thill G, Ji B, Relton J, Levesque M, Allaire N, Perrin S, Sands B, Crowell T, Cate RL, McCoy JM, Pepinsky RB. 2004. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci 7(3):221-228.
16. Murphy KC, Jones LA, Owen MJ. 1999. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 56(10):940-945.
17. Maynard TM, Haskell GT, Peters AZ, Sikich L, Lieberman JA, LaMantia AS. 2003. A comprehensive analysis of 22q11 gene expression in the developing and adult brain. Proc Natl Acad Sci U S A 100(24):14433-14438.
18. Ng CE, Tang BL. 2002. Nogos and the Nogo-66 receptor: factors inhibiting CNS neuron regeneration. J Neurosci Res 67(5):559-565.
19. Niederost B, Oertle T, Fritsche J, McKinney RA, Bandtlow CE. 2002. Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1. J Neurosci 22(23):10368-10376.
20. Novak G, Kim D, Seeman P, Tallerico T. 2002. Schizophrenia and Nogo: elevated mRNA in cortex, and high prevalence of a homozygous CAA insert. Brain Res Mol Brain Res 107(2):183-189.
21. Shifman S, Bronstein M, Sternfeld M, Pisante-Shalom A, Lev-Lehman E, Weizman A, Reznik I, Spivak B, Grisaru N, Karp L, Schiffer R, Kotler M, Strous RD, Swartz-Vanetik M, Knobler HY, Shinar E, Beckmann JS, Yakir B, Risch N, Zak NB, Darvasi A. 2002. A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 71(6):1296-1302.
22. Spalletta G, Tomaiuolo F, Marino V, Bonaviri G, Trequattrini A, Caltagirone C. 2003. Chronic schizophrenia as a brain misconnection syndrome: a white matter voxel-based morphometry study. Schizophr Res 64(1):15-23.
23. Tsuang MT and Faraone SV. 1998. Schizophrenia: epidemiology and genetic studies. IJP Psychiat Behav Sci 8:59-71.
24. Wang KC, Koprivica V, Kim JA, Sivasankaran R, Guo Y, Neve RL, He Z. 2002. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 417(6892):941-944.
25. Wong ST, Henley JR, Kanning KC, Huang KH, Bothwell M, Poo MM. 2002. A p75(NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein. Nat Neurosci 5(12):1302-1308.